In a systematic review and meta-analysis, researchers found higher BMI was associated with favorable clinical outcomes in patients with cystic fibrosis, urging reconsideration of the currently recommended target BMI.
“Currently, BMI is the generally accepted indicator for monitoring the nutritional status of patients with cystic fibrosis. In children older than 2 years, the target BMI is at least the 50th percentile; in adults, the target BMI is greater than or equal to 22 for women and greater than or equal to 23 for men,” Rita Nagy, MD, from the Institute for Translational